Ignite Creation Date:
2024-05-06 @ 7:47 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02600923
Status:
COMPLETED
Last Update Posted:
2022-01-20
First Post:
2015-11-06
Brief Title:
Palbociclib Plus Letrozole For Postmenopausal Women With HR HER2- Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-06
First Submit QC Date:
November 6 2015
Study First Post Date:
2015-11-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-05-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-18
Last Update Post Date:
2022-01-20
Last Update Post Date Type:
ACTUAL